Please use this identifier to cite or link to this item:
Title: Effectiveness of Sublingual Buprenorphine for Pain Control in the ICU
Authors: Patanwala, Asad E;Moran, Benjamin L ;Johnstone, Charlotte;Koelzow, Heike;Penm, Jonathan
Affliation: Central Coast Local Health District
Gosford Hospital
Issue Date: 1-Dec-2023
Source: 51(12):1650-1658
Journal title: Critical Care Medicine
Department: Surgery, Anaesthesia and ICU
Abstract: The objective of this study was to compare pain control and opioid consumption in critically ill patients who were treated with buprenorphine sublingual or oxycodone oral/enteral during ICU admission. This was a retrospective, parallel, cohort study. General medical or surgical ICUs of a quaternary, urban hospital in Sydney, NSW, Australia. Data were obtained for all patients admitted to two general medical or surgical ICU from January 2019 to January 2023. Patients were grouped as those who received buprenorphine sublingual versus oxycodone oral/enteral. None. Pain control was compared between a propensity score matched cohort of patients who received buprenorphine versus oxycodone. The primary outcome was the probability of significant pain. A significant pain score was defined as greater than or equal to 4 on the 0-10 Numeric Rating Scale or greater than or equal to 6 on the Behavioral Pain Scale. The study cohort included 1,070 patients (288 buprenorphine and 782 oxycodone). After propensity score matching, there were 288 patients in each group. The mean age of the matched cohort was 64 ± 16 years, 295 (51%) were male, and 359 (62%) had a surgical admission. The median probability of significant pain was 0.16 with buprenorphine and 0.17 with oxycodone (median difference, 0.01; 95% CI, -0.02 to 0.04; p = 0.50). Median opioid consumption in oral morphine milligram equivalents (MMEs) was 65 with buprenorphine and 70 with oxycodone (median difference, -1 mg; 95% CI, -10 to 10 mg; p = 0.73). Median MME per ICU day was 22 with buprenorphine and 22 with oxycodone (median difference, 1 mg; 95% CI, -2 to 5 mg; p = 0.38). Buprenorphine sublingual is as effective as oxycodone oral/enteral with regard to pain control and opioid consumption in the ICU. Buprenorphine sublingual is an appropriate option for patients in the ICU who are unable to take oral/enteral medications.
DOI: 10.1097/CCM.0000000000006031
Publicaton type: Journal Article
Keywords: Anesthetics
Study or Trial: Cohort Study
Appears in Collections:Health Service Research

Show full item record

Page view(s)

checked on Feb 26, 2024

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.